Job Description
Summary #LI-Hybrid

Location:
Toronto, Ontario Novartis is unable to offer relocation support for this role: please only apply if this location is accessible for you. This job posting is for an existing position Implement country-level health economics, pricing and reimbursement strategies to support timely listings and contract renewals for Novartis brands. Translate payer research into actionable insights, shape evidence-based pricing and market positioning, and lead cross-functional development of high-quality HTA and pricing and reimbursement submissions. Develop impactful product listing agreements and negotiation strategies in collaboration with Health Policy, Access, Medical and international HEOR partners. Develop robust economic evidence and clear value messages to support timely listing and optimal national patient access for Novartis brands. Lead HTA submissions for assigned assets, working with cross-functional partners to support the overall Access strategy. Interpret payer research and the Canadian reimbursement environment to identify opportunities, barriers and stakeholder needs for asset launches. Develop high-quality evidence dossiers, submission strategies, plans and deliverables for Canadian HTA and pricing and reimbursement bodies, including Canada’s Drug Agency and INESSS. Partner with Access, Medical, International HEOR and other internal stakeholders to define contracting strategies for new and existing products. Develop product listing agreements and negotiation strategies in collaboration with Health Policy and Access colleagues. Report product-related technical complaints, adverse events and special-case scenarios within 24 hours of receipt,



and support distribution of marketing samples where applicable. Relevant advanced education in health economics, epidemiology, biostatistics, outcomes research or a related discipline; solid English communication skills; Experience developing or contributing to HTA strategies, evidence dossiers and submissions for pharmaceutical assets. Knowledge across health economics, epidemiology, biostatistics, systematic reviews and market access. Ability to collaborate effectively across Access, Medical, HEOR and other cross-functional or international teams. At Novartis, we’re committed to reimagining medicine together
- and rewarding the people who make it happen. CAD 121,873 – 169,188 The base salary offered is determined based on gender-neutral objectives, such as relevant skills, competencies and experience in accordance with the Novartis pay setting policy and upon joining Novartis will be reviewed periodically. We also offer a variety of competitive advantages in kind to help you thrive personally and professionally, such as insurance plans, retirement plans, wellbeing resources and global recognition programs. In addition, we provide flexible and hybrid working options, where possible, and minimum 14 weeks paid parental leave. Pay equity is a fundamental principle of our employment policy and reflects our commitment to create a diverse,



equitable and inclusive environment that treats all employees with dignity and respect, as outlined in our Code of Ethics. Note: Benefits and compensation may vary by country and are subject to local legal requirements. Part of the way we are doing this is by leveraging data, technology, and partnerships. Research & Development Cardiovascular, Renal & Metabolic, Immunology, Neuroscience and Oncology. We also develop and deliver treatments through other promoted and established brands, which today are helping millions of patients. Over the last three years, our average annual research and development investment in Canada was over $30 million, and we conduct clinical trial research in every region throughout Canada. Commitment to Diversity and Inclusion Novartis is committed to building outstanding, inclusive work environment and diverse team’s representatives of the patients and communities we serve. Agility (Inactive), Cross-Functional Collaboration, Data Analysis, Employee Development, External Orientation (Inactive), Finance, Financial Analysis, Government Affairs, Healthcare Policies, Healthcare Sector Understanding (Inactive), Health Economics, Health Technology Assessment (HTA), Innovation, Market Access Strategies, People Management, Pricing Strategies, Public Health, Real World Evidence (RWE), Reimbursement Strategies, Research Methodologies, Results-Oriented, Statistical Analysis, Strategic Alliances It takes a focus on the needs of people and a community committed to meeting them. In the context of China Cross-Border Data Transfer (CBDT) policy, if you need to apply for a position in China, please go to the local Recruiting System TaleNov . #

📌 Manager, Health Economics and Outcomes Research (Toronto)
🏢 CA04 (FCRS = CA004) NOVARTIS PHARMA CANADA
📍 Toronto